Intas B2B Dossier e-portfolio
Published by: Intas Pharmaceuticals
Description
Access to Intas B2B portfolio Global-Dossiers: Biosimilars, Added Value Medicines and Generics.
Access to visual overviews on regulatory information and launch landscape.
Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.
Always updated with our last developments, filing plan and available MAs.
Hide
Show More...
Access to visual overviews on regulatory information and launch landscape.
Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.
Always updated with our last developments, filing plan and available MAs.
Screenshots
Intas B2B Dossier e FAQ
-
Is Intas B2B Dossier e free?
Yes, Intas B2B Dossier e is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Intas B2B Dossier e legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Intas B2B Dossier e cost?
Intas B2B Dossier e is free.
-
What is Intas B2B Dossier e revenue?
To get estimated revenue of Intas B2B Dossier e app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Malaysia yet.
Ratings History
Intas B2B Dossier e Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Intas B2B Dossier e Installs
Last 30 days
Intas B2B Dossier e Revenue
Last 30 daysIntas B2B Dossier e Revenue and Downloads
Gain valuable insights into Intas B2B Dossier e performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Intas Pharmaceuticals
- Languages
- English
- Recent release
- 5.0.3 (7 months ago )
- Released on
- Feb 23, 2016 (8 years ago )
- Also available in
- Spain, India, Portugal, Lebanon, Madagascar, Mexico, Malaysia, Netherlands, Norway, New Zealand, Philippines, Poland, South Korea, Romania, Russia, Saudi Arabia, Singapore, Thailand, Türkiye, Ukraine, United States, Vietnam, South Africa, Algeria, Austria, Brazil, Belarus, Canada, Switzerland, Chile, China, Czechia, Germany, Denmark, Kuwait, Egypt, France, United Kingdom, Greece, Indonesia, Ireland, Israel, Italy, United Arab Emirates
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.